Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03559595 · ClinicalTrials.gov registry record · NA
Increasing PrEP Among African Americans in Louisville KY
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 205
- Enrollment target
NCT03559595 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 205 participants.
The verdict
NCT03559595, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 205 participants
- Enrollment target
Study Summary
This study evaluates the effectiveness of a multifaceted strategy to increase pre-exposure prophylaxis (PrEP; a medication regimen to reduce HIV risk) uptake among high risk African Americans in Louisville, KY. We will do this by 1) implementing a media campaign to raise awareness about PrEP, 2) providing PrEP education to medical personnel who can prescribe PrEP, and 3) partnering with AIDS service organizations to improve outreach and linkage to PrEP services.
Interventions
- BEHAVIORAL Project Prevent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2018-06-04 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03559595
The ClinicalTrials.gov registry entry for NCT03559595 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Project Prevent is the first listed.
NCT03559595 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03559595 about?
NCT03559595 is a clinical study titled "Increasing PrEP Among African Americans in Louisville KY". This study evaluates the effectiveness of a multifaceted strategy to increase pre-exposure prophylaxis (PrEP; a medication regimen to reduce HIV risk) uptake among high risk African Americans in Louisville, KY. We will do this by 1) implementing a media campaign to raise awareness about PrEP, 2) pro...
What is the current status of trial NCT03559595?
This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2018-06-04. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03559595?
The interventions under investigation include: Project Prevent (BEHAVIORAL).
Who is sponsoring clinical trial NCT03559595?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.